BRIEF published on 08/15/2024 at 19:00, 1 year 7 months ago CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product International Expansion Medical Cannabis CannapharmaRx Cannabis Production Purchase Orders
PRESS RELEASE published on 08/15/2024 at 18:55, 1 year 7 months ago CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product CannaPharmaRx, Inc. receives 600KG cannabis orders from Cantek Holdings, further solidifying its position in the cannabis market internationally. Continues high-quality production at Cremona facility International Markets CannapharmaRx Cantek Holdings Cannabis Orders Cremona Facility
BRIEF published on 06/28/2024 at 09:05, 1 year 8 months ago CannaPharmaRx Reports Q1 2024 Financial Performance Financial Results Revenue Operating Expenses Licenses Strategic Agreements
PRESS RELEASE published on 06/28/2024 at 09:00, 1 year 8 months ago Q1 2024 Financial Results CannaPharmaRx reports Q1 2024 financial results with revenue commencing. The company anticipates accelerated growth, international expansion, and strategic partnerships Financial Results Revenue Growth Q1 2024 CannapharmaRx
BRIEF published on 05/20/2024 at 19:50, 1 year 10 months ago CannaPharmaRx to Host Investor Conference Call on May 21, 2024 Investor Conference Call Financial Update Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 19:45, 1 year 10 months ago CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. (OTC PINK:CPMD) will host an investor conference call on May 21, 2024, at 1PM Eastern time to provide updates on financials, products, distribution, and expansion Investor Conference Call Financial Update CannapharmaRx Cannabis Production CPMD
BRIEF published on 05/20/2024 at 18:35, 1 year 10 months ago CannaPharmaRx to Host Investor Conference Call Investor Conference Financial Update CannapharmaRx Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 18:30, 1 year 10 months ago CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. to hold investor conference call on May 21, 2024, providing updates on financials, products, orders, and forecasts. Visit www.cannapharmarx.com for details Investor Conference Call Financial Update CannapharmaRx Cannabis Production Forecasted Revenues
BRIEF published on 04/02/2024 at 12:05, 1 year 11 months ago CannapharmaRx Successfully Repays Convertible Notes to Strengthen Position Convertible Notes Debt Repayment Shareholder Interests CannapharmaRx Cannabis Production
PRESS RELEASE published on 04/02/2024 at 12:00, 1 year 11 months ago CannapharmaRx Pays Off Convertible Notes CannapharmaRx, Inc. announces the extinguishment of convertible notes to avoid stock dilution and strengthen the company. CEO Dean Medwid discusses the positive impact on future growth and valuation Convertible Notes Future Growth CannapharmaRx Stock Dilution CEO Dean Medwid
Published on 03/26/2026 at 13:00, 1 hour 40 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 1 hour 40 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 1 hour 41 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 1 hour 55 minutes ago Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia
Published on 03/26/2026 at 14:35, 5 minutes ago Guidepoint Library Surpasses 100,000 Transcripts, Scaling Real-Time Access to Expert Knowledge
Published on 03/26/2026 at 14:30, 10 minutes ago Delticom publishes Annual Report 2025: Revenues slightly higher than last year, dividend proposal of € 0.12 per share
Published on 03/26/2026 at 14:20, 20 minutes ago Hotel Sacher Vienna celebrates its 150th anniversary - with sculptures by Erwin Wurm
Published on 03/26/2026 at 14:18, 22 minutes ago RHÖN-KLINIKUM AG with consistent development in financial year 2025
Published on 03/26/2026 at 07:30, 7 hours 10 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 20 hours 9 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 20 hours 55 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
